FDA Advisory Panel Endorses Covid-19 Boosters for People 65-Plus or at High Risk of Severe Illness

  • 📰 WSJ
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

An FDA panel endorsed booster shots for people aged 65 and older, and those at high risk of severe Covid. It earlier rejected boosters for people 16 and older.

booster shots of the Covid-19 vaccine

from Pfizer Inc. and BioNTech SE for adults older than 65 years and those at high risk of severe disease, bringing the Biden administration one step closer to starting a booster campaign for millions of Americans. The outside panel on Friday voted 16-2 against advising the FDA to approve a booster dose of the Covid-19 vaccine from Pfizer Inc. and BioNTech SE at least six months after the second shot for people 16 years and older.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Hmm… Some experts must’ve thought it was questionable.

Thanks fda, the rest of the world can now get access to their first dose of pfizer vaccine

Poll to include at risk healthcare workers in EUA is confusing to me. Does this mean they're going to vote again on revised question? If so, when?

I have to ask: what happens when you turn 65?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

COVID-19 Vaccines Won’t Affect Your Sexual Performance, but COVID-19 MightJust in case you were wondering. I like your choice of that photo. Very fitting. mood😑
Source: SELFmagazine - 🏆 478. / 51 Read more »

FDA Panel Weighs Covid-19 Booster Shots as Health Officials Debate NeedThe Biden administration’s push to introduce widespread vaccine boosters faces a test as a Food and Drug Administration advisory panel meets to weigh evidence on the extra shots, a topic that has divided federal health officials. good luck Clown world What is there to weigh here. Either the science supports it or it doesn’t
Source: WSJ - 🏆 98. / 63 Read more »

FDA panel is first key test for Biden COVID-19 booster planGovernment advisers are debating whether to recommend extra doses of the Pfizer vaccine, a key step toward the Biden administration's plan to dispense COVID-19 booster shots. Scientists have been divided over the need for boosters and who should get them. The Delta variant was from December, 2020. This should be a no-brainer right now. Think more as clinicians and practitioners than researchers. Science is now a debate and not based off evidence or facts. Let that sink in.
Source: AP - 🏆 728. / 51 Read more »

FDA Questions Need For Pfizer Covid-19 Booster Shot Ahead Of Vote FridayScientists at the FDA said Pfizer’s Covid-19 vaccine seems to last long enough that a booster shot may not add much protection
Source: Forbes - 🏆 394. / 53 Read more »

FDA advisers vote to oppose Pfizer/BioNTech COVID-19 vaccine boosterA panel of outside advisers to the U.S. Food and Drug Administration on Friday voted against approval of a booster dose of the Pfizer Inc /BioNTech SE COVID-19 vaccine for people aged 16 and older. Wrong headline here. They voted against it for people as young as 16. They have not yet voted on it for adults 60 and older and those with compromised immunity.
Source: Reuters - 🏆 2. / 97 Read more »

Coronavirus update: FDA booster meeting and Covid-19 vaccine newsThe Food and Drug Administration's advisory committee is meeting today to discuss booster doses of coronavirus vaccine. Follow here for the latest news. 60+ should get 3rd shot. Period. This is NOT following the science...
Source: cnnbrk - 🏆 393. / 55 Read more »